On June 9, the Food and Drug Administration approved the first effective vaccine against Human Papillomavirus, a sexually transmitted infection that is one of the major causes of cervical cancer. On the heels of this approval, which represents a crucial breakthrough in the efforts of scientists, doctors and public health officials to combat the spread of STDs in the United States and elsewhere, the Medical College of Georgia announced today that significant strides have been made towards...
Read moreRecently, the United States Advisory Committee on Immunization Practices officially recommended that adults older than 60 years of age... Read more »
Recent studies suggest that 1 in 4 New Yorkers have genital herpes. Prior to this report, another study suggested that 1 in every 4... Read more »
Given the prevalence of herpes, and the constant turnover of men in my life, I was always surprised I hadn’t met a potential mate who... Read more »
Annual vaccinations for influenza virus are recommended for many groups of people. I strongly suggest that all people over the age of 65,... Read more »
A student has heard that a vaccine for herpes will be available in 2009 or 2010 and wonders if this will ever be a reality. A pre-medicine reporter... Read more »
Researchers say a new vaccine for melanoma has shown promise in clinical trials. In recent studies, eight melanoma patients achieved complete... Read more »
There is good news ahead for herpes patients, who usually suffer through a week of treatment before their pain and symptoms are resolved. The FDA has... Read more »
A U.S. company has been given British approval to start a Phase I clinical trial of a vaccine for genital herpes. The vaccine, called the ImmunoVEX... Read more »
A researcher at Southern Illinois University has received a $400,000 grant from the National Institute of Allergy and Infectious Disease to develop a... Read more »